Patents by Inventor David Simpkin

David Simpkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8685654
    Abstract: Influenza hemagglutinin (HA) binds to aluminum salt adjuvants and cannot easily be directly assayed directly a single radial immunodiffusion (SRID) test. The invention modifies the SRID protocol for an adsorbed antigen by including a step in which antigen is desorbed prior to diffusion.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: April 1, 2014
    Assignee: Novartis AG
    Inventors: Philip J. Sizer, Jane King-Haughey, David Simpkin, Roger Williams
  • Publication number: 20110045457
    Abstract: Influenza hemagglutinin (HA) binds to aluminium salt adjuvants and cannot easily be directly assayed directly a single radial immunodiffusion (SRID) test. The invention modifies the SRID protocol for an adsorbed antigen by including a step in which antigen is desorbed prior to diffusion.
    Type: Application
    Filed: December 24, 2008
    Publication date: February 24, 2011
    Applicant: NOVARTIS AG
    Inventors: Philip J. Sizer, Jane King-Haughey, David Simpkin, Roger Williams